Day One Biopharmaceuticals (DAWN) Earnings Date & Reports

A.I. Advisor

published Earnings

DAWN is expected to report earnings to rise 1,386.60% to -74 cents per share on November 04

Day One Biopharmaceuticals DAWN Stock Earnings Reports

Q3'24

Est.

$-0.74

Q2'24

Beat

by $0.70

Q1'24

Missed

by $0.07

Q4'23

Missed

by $0.06

Q3'23

Beat

by $0.05

The last earnings report on July 30 showed earnings per share of -5 cents, beating the estimate of -75 cents. With 466.01K shares outstanding, the current market capitalization sits at 1.43B.

View a ticker or compare two or three

Compare

DAWN

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For DAWN
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for DAWN (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

2000 Sierra Point Parkway

Phone

+1 650 484-0899

Employees

155

Web

https://www.dayonebio.com